Company Profile
Endonovo Therapeutics Stock Price, News & Catalysts
- Ticker:
- ENDV
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States and traded publicly
Stock performance
0.00 USD (0.00%)
Close
Last updated: August 17, 2026
—
Market cap
Why the stock is moving
As of Aug 17, 2026, ENDV was little changed and closed at $0.0001. No new same-company headline was identified in the current news window.
Company overview
Business overview
Endonovo Therapeutics was a medical technology company focused on bioelectronic or regenerative applications for inflammation and pain. Its story centered on device-based therapy rather than classic pharmaceuticals.
Geographic Base and Sector Classification
Endonovo was headquartered in the United States and traded publicly. It sat in medical technology and bioelectronic medicine.
Business Model Characteristics
The company depended on product development, commercialization, and the ability to show clinical utility. Investors historically watched device progress and strategic changes.
Position Within the Biotechnology Landscape
Endonovo occupies a historical bioelectronic-device niche. It is outside biotech therapeutics and more closely aligned with device-driven care.
Future catalysts
- Endonovo is a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update rather than a live product milestone. The market is focused on residual value.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Endonovo Therapeutics (ENDV)?
Endonovo Therapeutics (ENDV) most recently closed at 0.00 USD, a 0.00% move versus the previous session.
What does Endonovo Therapeutics do?
Endonovo Therapeutics was a medical technology company focused on bioelectronic or regenerative applications for inflammation and pain. Its story centered on device-based therapy rather than classic pharmaceuticals.
On which exchange is ENDV stock listed?
Endonovo Therapeutics (ENDV) is associated with NASDAQ, United States and traded publicly, Biopharma.
What is Endonovo?
Endonovo is a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update rather than a live product milestone.
Which conditions is Endonovo Therapeutics targeting with Endonovo?
Endonovo Therapeutics is associated with inflammatory disease based on its company overview and current catalyst commentary.
How does Endonovo Therapeutics describe recent progress with Endonovo?
Endonovo is a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update rather than a live product milestone.
What is Therapeutics?
Endonovo Therapeutics was a medical technology company focused on bioelectronic or regenerative applications for inflammation and pain.
What should investors watch for with Therapeutics?
Endonovo is a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update rather than a live product milestone. The market is focused on residual value.